GABA.ST
Gabather AB (publ) [GABA.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GABA.ST Stock Summary
Top 10 Correlated ETFs
GABA.ST
Top 10 Correlated Stocks
GABA.ST
In the News
GABA.ST Financial details
Company Rating
-
Market Cap
30.59M
Income
-9.43M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3
Optionable
No
Shortable
Yes
Earnings
05 Nov 2020
P/E
-2.79
Forward P/E
-
PEG
-8.79
P/S
-
P/B
156.6
P/C
-
P/FCF
-3.36
Quick Ratio
0.62
Current Ratio
1.02
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.65
EPS next Y
-
EPS next Q
-
EPS this Y
3.17%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
5.26%
-
-
-
-
SMA20
-33.33%
SMA50
-76.47%
SMA100
-92.31%
Inst Own
-
Inst Trans
-
ROA
-170%
ROE
-319%
ROC
-56.38%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.792-5.2
52W High
-
52W Low
-
RSI
39
Rel Volume
2.26
Avg Volume
38.14K
Volume
86.25K
Perf Week
10.38%
Perf Month
-38.41%
Perf Quarter
-92.23%
Perf Half Y
-93.13%
-
-
-
-
Beta
0.365
-
-
Volatility
0%, 0.01%
Prev Close
0.5%
Price
0.0404
Change
-5.16%
Company Profile
- Volume Average 38.14K
- Market Capitalization 30.59M
- Employee 3
- CEO Dr. Michael-Robin Witt
- Headquarters Södertälje,SE
- IPO Date 2014-11-03
-
Website
https://www.gabather.com 
Gabather AB (publ) develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company was incorporated in 2014 and is based in Södertälje Sweden.
